Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New imaging tool could cut unnecessary heart stents

NCT ID NCT07598565

First seen May 29, 2026 · Last updated Jun 19, 2026 · Updated 5 times

Summary

This study tests whether a new imaging technique called μFR can help doctors decide which blocked arteries need stents in heart attack patients with multiple blockages. About 350 patients will be randomly assigned to standard care or μFR-guided care. The goal is to see if μFR reduces the number of stents and procedures without increasing heart attacks or deaths.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES (ACS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Azienda ospedaliero - universitaria Sant'Andrea

    Roma, RM, 00189, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

μFR-guided procedure (imaging-based decision tool for stent placement)

What this could lead to

If successful, this could show that using μFR reduces unnecessary stents and procedures in heart attack patients, leading to safer, more targeted care.

What could go wrong

This is an early-stage trial with only 350 participants, and the μFR method may not accurately identify which blockages need treatment, potentially missing some that could cause future heart problems.

Conditions

The condition(s) this trial relates to.

acute coronary syndrome acute myocardial infarction coronary artery disorder ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.